SS-31 10mg 10vials

Description

SS-31 stands as the leading mitochondrial-targeted peptide for cellular energy optimization and comprehensive cellular health support. This clinically-validated compound offers researchers and health professionals an unprecedented tool for investigating mitochondrial function, cardiovascular protection, and neurological health applications.

What is SS-31?

SS-31 (Elamipretide) is a significant tetrapeptide engineered with specific molecular properties that enable selective mitochondrial targeting and cardiolipin stabilization. This unique mechanism provides targeted support for cellular energy production and oxidative stress protection.

SS-31 Benefits and Effects

1. Enhanced ATP Production: Significantly improves cellular energy generation through respiratory chain optimization2. Cardiolipin Stabilization: Protects and stabilizes critical mitochondrial membrane components3. Oxidative Stress Reduction: Provides targeted antioxidant protection within mitochondria4. Cardiovascular Support: Demonstrates significant benefits for heart function and circulation5. Neuroprotective Effects: Supports brain energy metabolism and neurological function6. Cellular Longevity: Promotes healthy aging through mitochondrial maintenance7. Exercise Performance: Enhances cellular energy capacity for physical performance8. Tissue Regeneration: Supports healing processes through improved cellular metabolism

SS-31 Side Effects and Safety

SS-31 demonstrates strong safety in clinical applications, with extensive research confirming its tolerability and minimal adverse effect profile across diverse populations.

1. Clinical Safety Record: Extensive human trials confirm excellent safety profile2. Mild Side Effects: Occasional injection site reactions, temporary energy fluctuations3. No Major Contraindications: Well-tolerated across age groups and health conditions4. Long-term Safety: Extended use studies show continued safety with monitoring5. Individual Responses: Adaptation period may involve temporary energy changes6. Monitoring Protocols: Regular assessments ensure continued safety and efficacy

Main SS-31 Use Cases

1. Cardiovascular Health: Heart failure, ischemic conditions, and cardiac aging research2. Neurological Support: Neurodegenerative conditions and cognitive function studies3. Aging Research: Mitochondrial aging mechanisms and longevity interventions4. Athletic Performance: Cellular energy optimization for enhanced physical capacity5. Metabolic Disorders: Research into energy metabolism and metabolic dysfunction6. Recovery Enhancement: Post-exercise recovery and tissue repair applications7. Clinical Research: Therapeutic applications for mitochondrial-related conditions

SS-31 Dosage Guidelines

1. Standard Research Dose: 20-40mg daily, administered subcutaneously2. Initial Assessment: Begin with 20mg to establish tolerance and response3. Therapeutic Research: 40mg daily for intensive therapeutic research protocols4. Maintenance Protocols: 20-30mg for long-term mitochondrial support studies5. Performance Research: 30-40mg for athletic and performance enhancement studies6. Clinical Applications: Dosing based on specific research objectives and safety parameters7. Individual Optimization: Adjust based on biomarker responses and research goals

SS-31 Cycle Guidelines

1. Continuous Administration: Daily dosing provides optimal mitochondrial support2. Research Cycles: 4-12 week study periods with comprehensive monitoring3. Long-term Protocols: Extended use with regular safety and efficacy assessments4. Biomarker Monitoring: Weekly assessments of mitochondrial function parameters5. Safety Evaluations: Regular cardiovascular and metabolic health assessments6. Protocol Adjustments: Modify based on individual response and research objectives

SS-31 Administration Guide

Proper administration technique ensures optimal research outcomes and maintains the integrity of this precision-engineered mitochondrial targeting system.

1. Reconstitution Protocol: Use sterile bacteriostatic water with gentle mixing2. Injection Technique: Subcutaneous administration with rotation of injection sites3. Timing Optimization: Consistent daily administration for sustained mitochondrial support4. Storage Management: Proper refrigeration maintains peptide stability and potency5. Quality Control: Visual inspection ensures solution clarity and integrity6. Documentation: Detailed records of administration and observed effects

SS-31 Treatment Duration

1. Acute Studies: 2-4 weeks for initial mitochondrial function assessment2. Standard Research: 8-12 weeks for comprehensive effect evaluation3. Long-term Investigations: 16+ weeks for sustained benefit assessment4. Chronic Conditions: Extended protocols with ongoing safety monitoring5. Performance Studies: 6-12 weeks aligned with training or competition cycles6. Clinical Applications: Duration based on therapeutic research objectives

SS-31 Storage Instructions

Maintaining optimal storage conditions preserves SS-31’s mitochondrial-targeting capabilities and ensures consistent research results.

1. Lyophilized Storage: -20??C freezer storage protects from degradation2. Reconstituted Management: 2-8??C refrigeration with 14-day use window3. Light Protection: Shield from direct light to maintain molecular stability4. Temperature Stability: Minimize temperature fluctuations during storage5. Quality Monitoring: Regular inspection for changes in appearance or clarity6. Handling Protocols: Sterile technique throughout preparation and storage

Why Choose SS-31 for Advanced Mitochondrial Research?

SS-31 represents the benchmark in mitochondrial-targeted research compounds, offering notable specificity and proven clinical efficacy. Its unique ability to concentrate within mitochondria provides researchers with precise tools for investigating cellular energy metabolism and developing therapeutic interventions.

Summary

SS-31 offers researchers and clinicians the most advanced mitochondrial support available, combining precise targeting mechanisms with comprehensive safety data. This new peptide provides strong opportunities for advancing mitochondrial research and developing therapeutic applications for age-related and metabolic conditions.

SS-31 FAQ

Q: What clinical evidence supports SS-31’s effectiveness?
A: Multiple Phase II trials demonstrate significant benefits for cardiovascular and mitochondrial function.

Q: How does SS-31 compare to other mitochondrial supplements?
A: SS-31’s targeted delivery system provides 1000-fold higher mitochondrial concentrations than oral supplements.

Q: Can SS-31 be combined with other research compounds?
A: Yes, but combination protocols require careful design and additional safety monitoring.

Q: What makes SS-31 suitable for long-term research?
A: Extensive safety data and stable formulation support extended research protocols.

Q: How quickly can mitochondrial improvements be measured?
A: Biomarker improvements often detectable within 7-14 days of consistent administration.